5830433M19Rik Activators
5830433M19Rik activators are a suite of chemical compounds that enhance the protein's functional activity by acting on various cellular signaling pathways. Forskolin, for instance, elevates intracellular cAMP levels, leading to PKA activation which may phosphorylate and enhance the activity of 5830433M19Rik if it is a PKA substrate. PMA, a PKC activator, and Ionomycin, which increases intracellular calcium, could also potentiate 5830433M19Rik activity through PKC-mediated phosphorylation or calcium-dependent signaling pathways. Retinoic Acid may indirectly upregulate 5830433M19Rik activity via nuclear receptor-mediated gene expression. Similarly, Sildenafil's inhibition of PDE5, preventing cAMP and cGMP breakdown, could lead to enhanced 5830433M19Rik activity within these pathways. EGCG, through kinase modulation, and Lithium Chloride, via GSK-3 inhibition, might upregulate 5830433M19Rik activity by targeting regulatory kinases involved in its control.
Additionally, compounds like LY294002 and SB203580, which inhibit PI3K and p38 MAPK respectively, may enhance 5830433M19Rik activity by disrupting negative feedback loops or shifting cellular signaling in favor of pathways that activate 5830433M19Rik. MEK1/2 inhibitor U0126 could indirectly increase 5830433M19Rik activity by reducing competitive ERK pathway signaling. The calcium ionophores A23187 and Ionomycin may also bolster 5830433M19Rik activity through calcium-dependent signaling. Lastly, the lipid signaling molecule Sphingosine-1-phosphate could enhance the functional activity of 5830433M19Rik by engaging S1P receptors and relevant downstream signaling cascades. Collectively, these activators exert their effects across a network of biochemical pathways, converging on the augmentation of 5830433M19Rik without necessitating direct binding or modification.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in a wide array of signaling pathways. Activation of PKC can enhance the functional activity of 5830433M19Rik if its activity is modulated by PKC-mediated phosphorylation or associated signaling pathways. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, activating calcium-dependent proteins and signaling pathways. This can lead to the activation of 5830433M19Rik if it is regulated by calcium signaling or calcium-binding proteins. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts through its nuclear receptors to regulate gene expression. If 5830433M19Rik is regulated by genes responsive to retinoic acid, its functional activity could be enhanced indirectly through these transcriptional changes. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can modulate kinase activity. If 5830433M19Rik is regulated by kinases that are sensitive to EGCG, its activity could be enhanced through the inhibition of competitive signaling pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3). If 5830433M19Rik is regulated by pathways involving GSK-3, inhibition by lithium could lead to enhanced activity of the protein. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can lead to changes in Akt signaling. If 5830433M19Rik functions downstream of PI3K/Akt pathway, inhibition of PI3K may relieve negative feedback loops, enhancing the activity of 5830433M19Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. Inhibition of p38 MAPK can shift the signaling balance in cells, potentially leading to activation of alternative pathways that could enhance the activity of 5830433M19Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, leading to reduced ERK pathway signaling. If 5830433M19Rik is activated by pathways that are suppressed by ERK signaling, U0126 could indirectly enhance its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium, similar to ionomycin. This can activate calcium-dependent signaling mechanisms that may enhance the functional activity of 5830433M19Rik. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) is a lipid signaling molecule that activates S1P receptors and downstream signaling pathways. If 5830433M19Rik is part of or regulated by S1P receptor signaling, its activity could be enhanced by S1P. | ||||||